Shares of Acorda Therapeutics Inc (NASDAQ:ACOR) are down nearly 5% in early trading Friday, after the drug maker announced that it will discontinue the development …
U.S.
Analysts weigh in on biotechnology company Conatus Pharmaceuticals Inc (NASDAQ:CNAT) and vision chip company Mobileye NV (NYSE:MBLY), as news of positive Phase II study of liver cirrhosis and strategic …
Analysts are weighing in on the pharmaceutical giant Pfizer Inc. (NYSE:PFE) and specialty-drug giant Allergan PLC (NYSE:AGN), as the companies announce a merger that will …
Following LinkedIn Corp’s (NYSE:LNKD) Q2 earnings report announcement on July 30, LinkedIn stock went on a roller coast ride. Shares soared about 12% …
Analysts are weighing in this afternoon on Gilead Sciences, Inc. (NASDAQ:GILD), after the U.
Gilead Sciences, Inc. (NASDAQ:GILD) is scheduled to report its second-quarter earnings after the bell on Tuesday and investors, first and foremost, will be looking …
In a research report published today, Evercore ISI analyst Duane Pfennigwerth maintained a Hold rating on Spirit Airlines (NASDAQ:SAVE) with an $85 price …
